Fellow/Senior Registrar (advanced trainee) in Haematology: Available from February 2024

Applications close Friday 29 September 2023

Exciting opportunities are available at Royal Perth Hospital (RPH) for a Fellow / Senior Registrar in clinical and laboratory haematology available from February 2024 for 12 months.

The position is suitable for trainees who have completed, or are completing, RACP and RCPA joint training in 2023 or 2024 and wish to develop further expertise in clinical research. Applicants need to have passed part 1 FRACP.

The laboratory is accredited for training by RCPA. The position is also suitable for an applicant who needs to complete one year of accredited laboratory only training and would like to develop further interests in translational research.

The following opportunities are available for an RACP/RCPA Fellow.

Position 1 is a Clinical Trials Fellow with the opportunity to coordinate and co-lead clinical trials across the spectrum of haematology malignancies. The clinical trials range from phase 1 to phase 3 including first in- human studies. The department focus is on acute myeloid leukaemia, myeloma and lymphoma and myeloproliferative disorders.

Position 2 is a Cellular Therapy Fellow. Working with Cell and Tissue Therapies of Western Australia (CTTWA) a facility on site at RPH responsible for stem cell processing for autologous stem cell transplants and the development of cellular therapies. The haematology department works closely CTTWA and is actively involved with a CAR-T cell therapy developmental program using autologous cells and trials of “off the shelf” allogeneic CAR-T cells.

All RPH Haematology Fellows/Registrars will have the opportunity to participate in translational research projects in collaboration with Professor Wendy Erber and her world class team at the University of Western Australia. Fellows have recently been successful applicants for research grants looking at:

• The role of plasma cfDNA (liquid biopsies) in the diagnosis and management of acute myeloid leukaemia and myelodysplastic syndromes.

• Improving the detection of 17p deletion in chronic lymphocytic leukaemia and multiple myeloma using novel immunoflow-FISH.

• Platelet transcriptome as novel biomarker in myeloproliferative neoplasms

  Responsibilities include a shared service commitment with other fellows and advanced trainees in performing and reporting bone marrow biopsies and reporting laboratory results including peripheral bloods and flow cytometry. Clinical responsibilities include inpatient care, outpatients and a consultative service and an on-call commitment.

  RCPA laboratory only trainees will have a reduced clinical role as per college requirements.

Please forward an expression of interest and a CV by Friday 29 September 2023 with the names and contact details (email and telephone number) of 2 referees to:

• Professor Michael Leahy
  Head of Haematology,
  Royal Perth Hospital, Perth, Western Australia michael.leahy@health.wa.gov.au

  +61 438 384 482